Key result
Age ≥80 linked to ~78% higher 1-year MACE after rotational atherectomy, driven by cardiac death.
Why the study?
Does rotational atherectomy in octogenarian and nonagenarian patients with severely calcified coronary lesions result in comparable in-hospital and 1-year outcomes compared to younger patients?
Observational (n=785)
No
Does rotational atherectomy in octogenarian and nonagenarian patients with severely calcified coronary lesions result in comparable in-hospital and 1-year outcomes compared to younger patients?
Rotational atherectomy is feasible and safe in octogenarian and nonagenarian patients with severely calcified coronary lesions, though they face higher 1-year mortality due to advanced age and comorbidities.
Answers are grounded in this paper and cite their sources.
May warrant caution in octogenarian/nonagenarian selection for rotational atherectomy; leaves open whether age-specific strategies improve 1-year outcomes.
INTRODUCTION: Severely calcified coronary lesions are a common challenge in older percutaneous coronary intervention (PCI) populations. We aimed to investigate in-hospital and 1-year outcomes of octogenarian and nonagenarian patients with heavily calcified coronary lesions treated with rotational atherectomy (RA). METHODS: Patients who underwent RA at our center were divided into two groups: octogenarians/nonagenarians (age ≥ 80 years) (n = 194) and younger counterparts (age < 80 years) (n = 591). Patients presented with acute coronary syndrome, and those treated with bare-metal stents were excluded. At 1 year, major adverse cardiac events (MACE) were investigated as a composite of cardiac death, spontaneous myocardial infarction (MI), or target lesion revascularization (TLR). RESULTS: In-hospital adverse outcome rates were 10.3% in the octogenarian/nonagenarian group versus 13.5% in the younger group (p = 0.266). Notably, the octogenarian/nonagenarian group had numerically higher in-hospital mortality (2.1% vs. 0.5%, p = 0.067). However, after adjusting for potential confounders, in-hospital mortality did not differ significantly between study arms (adj. HR 3.68; 95% CI 0.69-19.5, p = 0.126). At 1 year, the octogenarian/nonagenarian group was associated with a higher MACE rate (20% vs. 13%, adj. HR 1.78; 95% CI 1.27-2.50, p = 0.001), which was driven mainly by more cardiac deaths (13% vs. 4%, log-rank p < 0.001). Rates of MI (log-rank p = 0.708) and TLR (log-rank p = 0.333) were comparable between both study arms. CONCLUSIONS: RA is feasible in octogenarian and nonagenarian patients, with in-hospital adverse outcomes comparable to those of younger patients. Advanced age remains a strong predictor of 1-year MACE, given its inherently higher mortality. Graphical abstract available for this article.
No takes yet. Share an insight, caveat, or question.
Samy et al. (2026) conducted an observational in Severely calcified coronary lesions (n=785). Age ≥ 80 years (Octogenarians/Nonagenarians) vs. Age < 80 years was evaluated on 1-year major adverse cardiac events (MACE) (adj. HR 1.78, 95% CI 1.27-2.50, p=0.001). Octogenarian and nonagenarian patients undergoing rotational atherectomy had a significantly higher 1-year MACE rate compared to younger patients (20% vs. 13%, adj. HR 1.78), driven mainly by higher cardiac mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: